Ocup stock forecast.
In the last 12 months, OCUP had revenue of $57.21 million and earned $28.75 million in profits. Earnings per share was $1.42. Revenue. 57.21M.
Ocuphire Pharma stock price predictions for 2023, 2024, 2025, 2026, 2027 using artificial intelligence. How much will Ocuphire Pharma cost in 2023 – 2027?Find the latest Ocuphire Pharma, Inc. (OCUP) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.Stock Price Forecast. The 11 analysts offering 12-month price forecasts for YPF SA have a median target of 14.00, with a high estimate of 30.00 and a low estimate of 8.00. The median estimate ...In the last 12 months, OCUP had revenue of $57.21 million and earned $28.75 million in profits. Earnings per share was $1.42. Revenue. 57.21M.The 3 Wall Street analysts offering Ocuphire Pharma stock forecast in the last 6 months have average price target of $19.0 with a high forecast of $20.0 and a low forecast of $17.0. The average Ocuphire Pharma stock forecast represents a 535.45% increase from the last price of $2.99000000953674.
The AI-powered overall analysis of Ocuphire Pharma (OCUP) is based on the {{num_alpha_signal}} fundamental, technical, and sentiment features that are among the ones that had the greatest impact on the performance of …
In a report released today, Matthew Caufield from H.C. Wainwright reiterated a Buy rating on Ocuphire Pharma (OCUP – Research Report), with a price target of $20.00.The company’s shares closed ...
Based on analysts offering 12 month price targets for OCUP in the last 3 months. The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00 .Looking ahead, analysts expect 55% earnings growth this year, putting the stock’s forward price-earnings ratio at an equally-tiny 2.2-times. For 2024, these same analysts forecast 14% profit ...APYX Stock 12 Months Forecast. Average Price Target. $5.17 (102.75% Upside) Based on 5 Wall Street analysts offering 12 month price targets for Apyx Medical in the last 3 months. The average price target is $5.17 with a high forecast of $9.00 and a low forecast of $3.00.The average Rigetti Computing stock price prediction forecasts a potential upside of 185.71% from the current RGTI share price of $1.05. What is RGTI's forecast return on assets (ROA) for 2023-2024? (NASDAQ: RGTI) forecast ROA is -25.53%, which is lower than the forecast US Computer Hardware industry average of 11.16%.Nov 22, 2023 · According to the issued ratings of 2 analysts in the last year, the consensus rating for Ocuphire Pharma stock is Buy based on the current 2 buy ratings for OCUP. The average twelve-month price prediction for Ocuphire Pharma is $18.50 with a high price target of $20.00 and a low price target of $17.00. Learn more on OCUP's analyst rating history.
With stocks at historic highs, many individuals are wondering if the time is right to make their first foray in the stock market. The truth is, there is a high number of great stocks to buy today. However, you might be unsure how to begin.
The average Ocuphire Pharma stock price prediction forecasts a potential upside of 585.19% from the current OCUP share price of $2.70. What is OCUP's forecast return …
May 14, 2023 · Ocuphire Pharma's (NASDAQ:OCUP) stock is up by a considerable 60% over the past three months. As most would know, fundamentals are what usually guide market price movements over the long-term, so ... Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Market cap is calculated by taking a company's price per share and multiplying it by the company's total number of shares outstanding. $4.04B. -. Market Cap / Employee. The market cap of a company ...In the world of business, cash flow is king. Having a clear understanding of your company’s cash flow is essential for making informed financial decisions and ensuring the long-term success of your business.Nov 21, 2023 · Coupa Software Stock Forecast and Price Target. The average target price for Coupa Software's stock set by renowned analysts in recent months is $90.00, representing a potential downside of approximately -94.04% from its last closing price if met by 2024. This estimation is based on a high estimate of $320.00 and a low estimate of $65.00.
Ocuphire Pharma, Inc. Common Stock (OCUP) Real-time Stock Quotes - Nasdaq offers real-time quotes & market activity data for US and global markets.In the last 12 months, OCUP had revenue of $57.21 million and earned $28.75 million in profits. Earnings per share was $1.42. Revenue. 57.21M.Its stock still isn't cheap relative to those of its cloud-based peers. Motley Fool Issues Rare “All In” Buy Alert. ... which also cleared the consensus forecast by $0.22. On a non-GAAP basis ...Based on the Ocuphire Pharma Inc stock forecast from 2 analysts, the average analyst target price for Ocuphire Pharma Inc is USD 19.00 over the next 12 months. Ocuphire Pharma Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Ocuphire Pharma Inc is Slightly Bullish , which is based on 6 positive ... KNTE Stock 12 Months Forecast. Based on 6 Wall Street analysts offering 12 month price targets for Kinnate Biopharma in the last 3 months. The average price target is $2.70 with a high forecast of $4.00 and a low forecast of $1.50. The average price target represents a 20.00% change from the last price of $2.25.
COUP stock climbed as Coupa Software reported earnings and revenue that topped estimates and announced a $100 million buyback. ... The software company forecast revenue of $212.5 million at the ...
For Coupa Software Incorporated stock forecast for 2031, 12 predictions are offered for each month of 2031 with average Coupa Software Incorporated stock forecast of $57.37, a high forecast of $57.7, and a low forecast of $57.19. The average Coupa Software Incorporated stock forecast 2031 represents a -27.69% decrease from the last price of …May 14, 2023 · Ocuphire Pharma's (NASDAQ:OCUP) stock is up by a considerable 60% over the past three months. As most would know, fundamentals are what usually guide market price movements over the long-term, so ... Targets: Pharmacologically-induced Mydriasis, Presbyopia, and Dim Light or Night Vision Disturbances. Phentolamine Ophthalmic Solution 0.75% Eye Drops is a once-daily preservative-free eye drop formulation designed to reduce pupil size and improve visual acuity. View Phentolamine Ophthalmic Solution 0.75%.In the dynamic world of stock trading, analysts and investors closely observe the projected highs and lows of Coupa Software shares. Our integrated forecast predicts a peak price of $101.26 in the forthcoming 30 days, indicating the zenith of the stock's potential performance. An encouraging revelation, denoting an upside potential of …OCUP : Ocuphire Pharma stock forecast, predictions, and share price target for 2022, 2023 (1 year) to 2025 - 2027 (5 year) to 2030, and 2032 (10 year) with Revenue and EPS Prognosis by Technical AnalysisNov 30, 2023 · 1 Wall Street analysts have issued twelve-month target prices for Diversified Healthcare Trust's stock. Their DHC share price targets range from $4.50 to $4.50. On average, they expect the company's share price to reach $4.50 in the next year. This suggests a possible upside of 119.5% from the stock's current price.
Target values for the price of one Coupa Software share for Mar 2024. The weighted average target price per Coupa Software share in Mar 2024 is: 94.98. In Mar, the Positive dynamics for Momo shares will prevail with possible monthly volatility of 10.317% volatility is expected. Pessimistic target level: 89.17.
When planning outdoor activities or making travel arrangements, having access to accurate weather forecasts is crucial. One commonly used tool is the 7 day weather forecast, which provides an outlook for the upcoming week.
As of last trade, Ocuphire Pharma Inc (OCUP:NAQ) traded at 2.87, 15.73% above the 52 week low of 2.48 set on Dec 27, 2022. Data delayed at least 15 minutes, as of Dec 04 2023 18:10 GMT. Latest Ocuphire Pharma Inc (OCUP:NAQ) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and more.In the dynamic world of stock trading, precise and comprehensive forecasts are crucial. For investors eyeing Coupa Software and its promising trajectory, we have meticulously collated insights from various analyst forecasts. Our consensus forecast for 2022 is a composite reflection of diverse expert analyses, ensuring a balanced and …You may have a lot of questions if you are interested in investing in the stock market for the first time. One question that beginning investors often ask is whether they need a broker to begin trading.In the last 12 months, OCUP had revenue of $57.21 million and earned $28.75 million in profits. Earnings per share was $1.42. Revenue. 57.21M.OCUP Overview Stock Screener Earnings Calendar Sectors Nasdaq | OCUP U.S.: Nasdaq Ocuphire Pharma Inc. Watch list NEW Set a price target alert After Hours Last Updated: …Ocuphire Pharma Inc. 2.75. Delayed Data. As of Nov 29. +0.04 / +1.48%. Today’s Change. 2.48. Today ||| 52-Week Range. 6.60. South African Factory Manager Outlook Worst Since Covid Lockdown. Economics. Investment Gap Dragging Down UK Living Standards, Bloomberg …Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Coupa Software (COUP) stock sank 28.5% postmarket after the firm provided forecast for 2023 that widely missed Street estimates, despite posting better-than-expected Q4 results.COUP...Find the latest Ocuphire Pharma, Inc. OCUP analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports. Date Range. investment rating. report type ...Oct 26, 2021 · OCUP : Ocuphire Pharma stock forecast, predictions, and share price target for 2022, 2023 (1 year) to 2025 - 2027 (5 year) to 2030, and 2032 (10 year) with Revenue and EPS Prognosis by Technical Analysis Performance was better than the analysts expected, with revenues of US$40m coming in42% ahead of expectations, and statutory earnings per share (EPS) of US$0.87 exceeding forecasts by 18%.
Forecst.com predicts future values using technical analysis of a large number of analytical parameters. OCUP stock returns are also predicted based on historical data. According to our research, OCUP stock is a bad long-term investment. OCUP share price has been in a bear cycle for the past year. Ocuphire Pharma, Inc. stock trend is negative .Nov 24, 2023 · Based on short-term price targets offered by two analysts, the average price target for Ocuphire Pharma, Inc. comes to $18.00. The forecasts range from a low of $16.00 to a high of $20.00. The ... In the dynamic world of stock trading, precise and comprehensive forecasts are crucial. For investors eyeing Ocuphire Pharma and its promising trajectory, we have meticulously collated insights from various analyst forecasts. Our consensus forecast for 2023 is a composite reflection of diverse expert analyses, ensuring a balanced and …Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET.Instagram:https://instagram. artistdirectbest food truck insurancestock klacotcmkts pcrfy Investing in the stock market takes a lot of courage, a lot of research, and a lot of wisdom. One of the most important steps is understanding how a stock has performed in the past. Of course, the past is not a guarantee of future performan...The 5 analysts offering 1 year price forecasts for OCUP have a max estimate of — and a min estimate of —. Analyst rating Based on 5 analysts giving stock ratings to OCUP in the past 3 months. diagnoshow to read charts stocks The maker of business spending management software forecast revenue in a range of $202 million to $205 million, slightly below estimates of $205.3 million. San Mateo, Calif.-based Coupa reported ... best growth funds See the latest Coupa Software Inc stock price (COUP:XMEX), related news, valuation, dividends and more to help you make your investing decisions.Nov 27, 2023 · The Ocuphire Pharma, Inc. stock price fell by -1.24% on the last day (Monday, 27th Nov 2023) from $2.83 to $2.79. During the last trading day the stock fluctuated 11.74% from a day low at $2.63 to a day high of $2.94. The price has fallen in 6 of the last 10 days and is down by -1.41% for this period. Volume has increased on the last day by 277 ... Find the latest Ocuphire Pharma, Inc. (OCUP) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.